Are no longer solely to blame for peripartum cardiomyopathy (though they are implicated). Fifteen percent of affected women were found to have a harmful gene variant seen in other dilated cardiomyopathies. There is currently no treatment for heart failure from peripartum cardiomyopathy, but investigators hope gene testing will make way for future therapies.
NEJM
|